| 产品详情 |
| Edit |   |
|---|
| Product Name | Salinosporamide A |
|---|
| Description | Purity ≥95% (HPLC). Potent, irreversible inhibitor of all the 3 proteolytic activities of the mammalian 20S proteasome. -beta5 subunit: chymotrypsin-like (EC50 = 3.5nM) -beta2 subunit: trypsin-like (EC50 = 28nM) -beta1 subunit: caspase-like or peptidyl-glutamyl peptide-hydrolyzing (PGPH) (EC50 = 430nM) Potent anticancer compound. Triggers apoptosis, with distinct proteasome activity and mechanism of action compared to bortezomib (Velcade). Most potent suppressor of NF-kB activation, compared with bortezomib, MG-132, N-acetyl-leucyl-leucyl-norleucinal (ALLN) and lactacystin. Inhibitor of TNF-alpha, IL-1, IL-6, ICAM-1 and VEGF synthesis. Displays a longer inhibition duration than bortezomib. Potent antileukemic activity against bortezomib-resistant leukemia cells. Solubility: Soluble in DMSO. Do not dissolve in methanol or ethanol. |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | SalA; Marizomib; NPI-0052 |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 226808 |
|---|
| Price | |
|---|
| Order / More Info | Salinosporamide A from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|